- Home
- HUDI vs TENX Comparison
HUDI vs TENX Comparison
Compare HUDI & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- TENX
- Stock Information
- Founded
- HUDI 1998
- TENX 1967
- Country
- HUDI China
- TENX United States
- Employees
- HUDI N/A
- TENX N/A
- Industry
- HUDI Steel/Iron Ore
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- TENX Health Care
- Exchange
- HUDI Nasdaq
- TENX Nasdaq
- Market Cap
- HUDI 23.2M
- TENX 21.8M
- IPO Year
- HUDI 2021
- TENX N/A
- Fundamental
- Price
- HUDI $1.65
- TENX $6.50
- Analyst Decision
- HUDI
- TENX Strong Buy
- Analyst Count
- HUDI 0
- TENX 4
- Target Price
- HUDI N/A
- TENX $20.67
- AVG Volume (30 Days)
- HUDI 20.7K
- TENX 36.1K
- Earning Date
- HUDI 02-03-2025
- TENX 11-13-2024
- Dividend Yield
- HUDI N/A
- TENX N/A
- EPS Growth
- HUDI N/A
- TENX N/A
- EPS
- HUDI 0.18
- TENX N/A
- Revenue
- HUDI $83,462,634.00
- TENX N/A
- Revenue This Year
- HUDI N/A
- TENX N/A
- Revenue Next Year
- HUDI N/A
- TENX N/A
- P/E Ratio
- HUDI $9.23
- TENX N/A
- Revenue Growth
- HUDI 7.65
- TENX N/A
- 52 Week Low
- HUDI $1.55
- TENX $2.77
- 52 Week High
- HUDI $4.25
- TENX $21.46
- Technical
- Relative Strength Index (RSI)
- HUDI 42.69
- TENX 60.16
- Support Level
- HUDI $1.63
- TENX $6.20
- Resistance Level
- HUDI $1.70
- TENX $6.73
- Average True Range (ATR)
- HUDI 0.11
- TENX 0.36
- MACD
- HUDI 0.01
- TENX -0.02
- Stochastic Oscillator
- HUDI 6.66
- TENX 72.05
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Products are exported to the United States, Mexico, Thailand, Australia, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.